Terms: = Leukemia AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Treatment
73 results:
1. Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth.
Kellaway SG; Potluri S; Keane P; Blair HJ; Ames L; Worker A; Chin PS; Ptasinska A; Derevyanko PK; Adamo A; Coleman DJL; Khan N; Assi SA; Krippner-Heidenreich A; Raghavan M; Cockerill PN; Heidenreich O; Bonifer C
Nat Commun; 2024 Feb; 15(1):1359. PubMed ID: 38355578
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
Birdwell CE; Fiskus W; Kadia TM; Mill CP; Sasaki K; Daver N; DiNardo CD; Pemmaraju N; Borthakur G; Davis JA; Das K; Sharma S; Horrigan S; Ruan X; Su X; Khoury JD; Kantarjian H; Bhalla KN
Leukemia; 2024 Mar; 38(3):545-556. PubMed ID: 38086946
[TBL] [Abstract] [Full Text] [Related]
3. Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemia.
Kelesoglu N; Kori M; Yilmaz BK; Duru OA; Arga KY
Cancer Med; 2023 Dec; 12(24):22420-22436. PubMed ID: 38069522
[TBL] [Abstract] [Full Text] [Related]
4. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
Williams LS; Williams KM; Gillis N; Bolton K; Damm F; Deuitch NT; Farhadfar N; Gergis U; Keel SB; Michelis FV; Panch SR; Porter CC; Sucheston-Campbell L; Tamari R; Stefanski HE; Godley LA; Lai C
Transplant Cell Ther; 2024 Mar; 30(3):255-267. PubMed ID: 37913908
[TBL] [Abstract] [Full Text] [Related]
5. TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing gata2 expression.
Heyes E; Wilhelmson AS; Wenzel A; Manhart G; Eder T; Schuster MB; Rzepa E; Pundhir S; D'Altri T; Frank AK; Gentil C; Woessmann J; Schoof EM; Meggendorfer M; Schwaller J; Haferlach T; Grebien F; Porse BT
Nat Commun; 2023 Oct; 14(1):6185. PubMed ID: 37794021
[TBL] [Abstract] [Full Text] [Related]
6. Analysis and clinical characteristics of acute myeloid leukemia developing with prior or concurrent tumors in non cyto- or radiotherapy exposure patients in a single center.
Lian Y; Ti J; Ma L; Wei J; Gao Z
Hematology; 2023 Dec; 28(1):2230738. PubMed ID: 37427790
[No Abstract] [Full Text] [Related]
7. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
[TBL] [Abstract] [Full Text] [Related]
8. Case report: Successful allogeneic stem cell transplantation in a child with novel gata2 defect associated B-cell acute lymphoblastic leukemia.
Heropolitańska-Pliszka E; Piątosa B; Szmydki-Baran A; Kuczborska K; Miarka-Walczyk K; Pastorczak A; Młynarski W; Sędek Ł; Szczepański T; Ussowicz M
Front Immunol; 2022; 13():928529. PubMed ID: 35983050
[TBL] [Abstract] [Full Text] [Related]
9. GATA 2 Deficiency: Focus on Immune System Impairment.
Fabozzi F; Mastronuzzi A; Ceglie G; Masetti R; Leardini D
Front Immunol; 2022; 13():865773. PubMed ID: 35769478
[TBL] [Abstract] [Full Text] [Related]
10. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling.
Kang Y; Lin J; Wang L; Shen X; Li J; Wu A; Yue L; Wei L; Ye Y; Yang J; Wu J
Phytomedicine; 2022 Jul; 102():154150. PubMed ID: 35569185
[TBL] [Abstract] [Full Text] [Related]
11. Single-Nucleotide Variations, Insertions/Deletions and Copy Number Variations in Myelodysplastic Syndrome during Disease Progression Revealed by a Single-Cell DNA Sequencing Platform.
Lee P; Yim R; Fung SH; Miu KK; Wang Z; Wu KC; Au L; Leung GM; Lee VH; Gill H
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563039
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and Genomic Profiles of Korean Patients with
Lee J; Kim SM; Kim S; Yun J; Jeong D; Lee YE; Roh EY; Lee DS
Ann Lab Med; 2022 Sep; 42(5):590-596. PubMed ID: 35470277
[TBL] [Abstract] [Full Text] [Related]
13. Hematopoietic stem cell transplantation in children and adolescents with gata2-related myelodysplastic syndrome.
Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
[TBL] [Abstract] [Full Text] [Related]
14. Therapeutic options for CTLA-4 insufficiency.
Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
[TBL] [Abstract] [Full Text] [Related]
15. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
Chen X; Fan S; Zhao Y; Zhou J
Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
[TBL] [Abstract] [Full Text] [Related]
16. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptional regulation of lysophosphatidic acid receptors 2 and 3 regulates myeloid commitment of hematopoietic stem cells.
Lin KH; Chiang JC; Chen WM; Ho YH; Yao CL; Lee H
Am J Physiol Cell Physiol; 2021 Apr; 320(4):C509-C519. PubMed ID: 33406026
[TBL] [Abstract] [Full Text] [Related]
18. Venetoclax/decitabine for a pediatric patient with chronic myelomonocytic leukemia.
Molina JC; Asare JM; Tuschong L; West RR; Calvo KR; Persky R; Boyce AM; Hammoud DA; Holland SM; Hickstein D; Shah NN
Pediatr Blood Cancer; 2021 Mar; 68(3):e28865. PubMed ID: 33369023
[TBL] [Abstract] [Full Text] [Related]
19. [Effect of Signal Transduction Pathway Gene Mutations on the One- course Induced Remission Rate and Analysis of Clinical Characteristics in Patients with CBF-AML].
Fan LF; Xu J; Chen XH; Tian TT; Xie J; Hu JJ; Guo ZP; Tan YH; Xu ZF; Ren FG; Zhang YF; Luo M; Ren WX; Wang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):781-788. PubMed ID: 32552936
[TBL] [Abstract] [Full Text] [Related]
20. Secondary leukemia in patients with germline transcription factor mutations (RUNX1, gata2, CEBPA).
Brown AL; Hahn CN; Scott HS
Blood; 2020 Jul; 136(1):24-35. PubMed ID: 32430494
[TBL] [Abstract] [Full Text] [Related]
[Next]
